» Articles » PMID: 36120584

Extracellular Vesicles in Cardiac Repair and Regeneration: Beyond Stem-cell-based Approaches

Overview
Specialty Cell Biology
Date 2022 Sep 19
PMID 36120584
Authors
Affiliations
Soon will be listed here.
Abstract

The adult human heart poorly regenerate after injury due to the low self-renewal capability retained by adult cardiomyocytes. In the last two decades, several clinical studies have reported the ability of stem cells to induce cardiac regeneration. However, low cell integration and survival into the tissue has limited stem-cell-based clinical approaches. More recently, the release of paracrine mediators including extracellular vesicles (EV) has been recognized as the most relevant mechanism driving benefits upon cell-based therapy. In particular, EV have emerged as key mediators of cardiac repair after damage, in terms of reduction of apoptosis, resolution of inflammation and new blood vessel formation. Herein, mechanisms involved in cardiac damage and regeneration, and current applications of EV and their small non-coding RNAs (miRNAs) in regenerative medicine are discussed.

Citing Articles

Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications.

Rayat Pisheh H, Darvishi A, Masoomkhah S Front Bioeng Biotechnol. 2025; 12:1521462.

PMID: 39758951 PMC: 11696288. DOI: 10.3389/fbioe.2024.1521462.


Extracellular vesicle therapeutics for cardiac repair.

Hu Y, Zhang W, Ali S, Takeda K, Vahl T, Zhu D J Mol Cell Cardiol. 2024; 199:12-32.

PMID: 39603560 PMC: 11788051. DOI: 10.1016/j.yjmcc.2024.11.005.


Anti-inflammatory, Anti-fibrotic and Pro-cardiomyogenic Effects of Genetically Engineered Extracellular Vesicles Enriched in miR-1 and miR-199a on Human Cardiac Fibroblasts.

Kmiotek-Wasylewska K, Bobis-Wozowicz S, Karnas E, Orpel M, Woznicka O, Madeja Z Stem Cell Rev Rep. 2023; 19(8):2756-2773.

PMID: 37700183 PMC: 10661813. DOI: 10.1007/s12015-023-10621-2.


Charting the Path: Navigating Embryonic Development to Potentially Safeguard against Congenital Heart Defects.

Braganca J, Pinto R, Silva B, Marques N, Leitao H, Fernandes M J Pers Med. 2023; 13(8).

PMID: 37623513 PMC: 10455635. DOI: 10.3390/jpm13081263.

References
1.
Hassink R, Pasumarthi K, Nakajima H, Rubart M, Soonpaa M, de la Riviere A . Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res. 2007; 78(1):18-25. PMC: 2653079. DOI: 10.1093/cvr/cvm101. View

2.
Uemura R, Xu M, Ahmad N, Ashraf M . Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006; 98(11):1414-21. DOI: 10.1161/01.RES.0000225952.61196.39. View

3.
Lai S, Marin-Juez R, Stainier D . Immune responses in cardiac repair and regeneration: a comparative point of view. Cell Mol Life Sci. 2018; 76(7):1365-1380. PMC: 6420886. DOI: 10.1007/s00018-018-2995-5. View

4.
Umar S, van der Laarse A . Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2009; 333(1-2):191-201. DOI: 10.1007/s11010-009-0219-x. View

5.
Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View